Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.

Anstey NM, Douglas NM, Poespoprodjo JR, Price RN.

Adv Parasitol. 2012;80:151-201. doi: 10.1016/B978-0-12-397900-1.00003-7. Review.

PMID:
23199488
2.

Effects of Plasmodium vivax malaria in pregnancy.

Nosten F, McGready R, Simpson JA, Thwai KL, Balkan S, Cho T, Hkirijaroen L, Looareesuwan S, White NJ.

Lancet. 1999 Aug 14;354(9178):546-9.

PMID:
10470698
3.

On the pathogenesis of Plasmodium vivax malaria: perspectives from the Brazilian field.

Costa FT, Lopes SC, Albrecht L, Ataíde R, Siqueira AM, Souza RM, Russell B, Renia L, Marinho CR, Lacerda MV.

Int J Parasitol. 2012 Nov;42(12):1099-105. doi: 10.1016/j.ijpara.2012.08.007. Epub 2012 Sep 26. Review.

PMID:
23022617
4.

The anaemia of Plasmodium vivax malaria.

Douglas NM, Anstey NM, Buffet PA, Poespoprodjo JR, Yeo TW, White NJ, Price RN.

Malar J. 2012 Apr 27;11:135. doi: 10.1186/1475-2875-11-135. Review.

5.

The pathophysiology of vivax malaria.

Anstey NM, Russell B, Yeo TW, Price RN.

Trends Parasitol. 2009 May;25(5):220-7. doi: 10.1016/j.pt.2009.02.003. Epub 2009 Apr 6. Review.

PMID:
19349210
6.

[Plasmodium vivax infection: not so benign].

Picot S, Bienvenu AL.

Med Sci (Paris). 2009 Jun-Jul;25(6-7):622-6. doi: 10.1051/medsci/2009256-7622. Review. French.

7.

Understanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literature.

Lacerda MV, Mourão MP, Alexandre MA, Siqueira AM, Magalhães BM, Martinez-Espinosa FE, Filho FS, Brasil P, Ventura AM, Tada MS, Couto VS, Silva AR, Silva RS, Alecrim MG.

Malar J. 2012 Jan 9;11:12. doi: 10.1186/1475-2875-11-12. Review.

8.

Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.

Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Warikar N, Seal A, McGready R, Sugiarto P, Tjitra E, Anstey NM, Price RN.

Clin Infect Dis. 2008 May 1;46(9):1374-81. doi: 10.1086/586743.

9.

Severe disease in children hospitalized with a diagnosis of Plasmodium vivax in south-eastern Pakistan.

Shaikh S, Memon H, Iohano B, Shaikh A, Ahmed I, Baird JK.

Malar J. 2012 May 2;11:144. doi: 10.1186/1475-2875-11-144.

10.

Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study.

McGready R, Lee SJ, Wiladphaingern J, Ashley EA, Rijken MJ, Boel M, Simpson JA, Paw MK, Pimanpanarak M, Mu O, Singhasivanon P, White NJ, Nosten FH.

Lancet Infect Dis. 2012 May;12(5):388-96. doi: 10.1016/S1473-3099(11)70339-5. Epub 2011 Dec 12.

11.

New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.

Price RN, Douglas NM, Anstey NM.

Curr Opin Infect Dis. 2009 Oct;22(5):430-5. doi: 10.1097/QCO.0b013e32832f14c1. Review.

PMID:
19571748
12.

The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission.

McGready R, Davison BB, Stepniewska K, Cho T, Shee H, Brockman A, Udomsangpetch R, Looareesuwan S, White NJ, Meshnick SR, Nosten F.

Am J Trop Med Hyg. 2004 Apr;70(4):398-407.

PMID:
15100454
13.

A morphometric and histological study of placental malaria shows significant changes to villous architecture in both Plasmodium falciparum and Plasmodium vivax infection.

Chaikitgosiyakul S, Rijken MJ, Muehlenbachs A, Lee SJ, Chaisri U, Viriyavejakul P, Turner GD, Pongponratn E, Nosten F, McGready R.

Malar J. 2014 Jan 4;13:4. doi: 10.1186/1475-2875-13-4.

14.

Lack of associations of α(+)-thalassemia with the risk of Plasmodium falciparum and Plasmodium vivax infection and disease in a cohort of children aged 3-21 months from Papua New Guinea.

Rosanas-Urgell A, Senn N, Rarau P, Aponte JJ, Reeder JC, Siba PM, Michon P, Mueller I.

Int J Parasitol. 2012 Nov;42(12):1107-13. doi: 10.1016/j.ijpara.2012.10.001. Epub 2012 Oct 17.

PMID:
23085147
15.

Clinical features of children hospitalized with malaria--a study from Bikaner, northwest India.

Kochar DK, Tanwar GS, Khatri PC, Kochar SK, Sengar GS, Gupta A, Kochar A, Middha S, Acharya J, Saxena V, Pakalapati D, Garg S, Das A.

Am J Trop Med Hyg. 2010 Nov;83(5):981-9. doi: 10.4269/ajtmh.2010.09-0633.

16.

Clinico-pathological studies of Plasmodium falciparum and Plasmodium vivax - malaria in India and Saudi Arabia.

Khan W, Zakai HA, Umm-E-Asma.

Acta Parasitol. 2014 Jun;59(2):206-12. doi: 10.2478/s11686-014-0227-1. Epub 2014 May 15.

PMID:
24827088
17.

Global Epidemiology of Plasmodium vivax.

Howes RE, Battle KE, Mendis KN, Smith DL, Cibulskis RE, Baird JK, Hay SI.

Am J Trop Med Hyg. 2016 Dec 28;95(6 Suppl):15-34. doi: 10.4269/ajtmh.16-0141. Epub 2016 Jul 11. Review.

18.

Relapse.

White NJ, Imwong M.

Adv Parasitol. 2012;80:113-50. doi: 10.1016/B978-0-12-397900-1.00002-5. Review.

PMID:
23199487
19.

Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria.

Barber BE, William T, Grigg MJ, Parameswaran U, Piera KA, Price RN, Yeo TW, Anstey NM.

PLoS Pathog. 2015 Jan 8;11(1):e1004558. doi: 10.1371/journal.ppat.1004558. eCollection 2015 Jan.

20.

Severe Plasmodium falciparum and Plasmodium vivax malaria among adults at Kassala Hospital, eastern Sudan.

Abdallah TM, Abdeen MT, Ahmed IS, Hamdan HZ, Magzoub M, Adam I.

Malar J. 2013 May 1;12:148. doi: 10.1186/1475-2875-12-148.

Supplemental Content

Support Center